Browsing Pharmacy and Pharmaceutical Sciences by Subject "Benefit/risk assessment"
Now showing items 1-1 of 1
-
COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?
(2020)Background: Current recommendations for the self-management of SARS-Cov-2 disease (COVID-19) include self-isolation, rest, hydration, and the use of NSAID in case of high fever only. It is expected that many patients will ...
